Biopharmaceutical Market 2023 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Biopharmaceutical market
Biopharmaceutical Market: By Source (Unicellular & Multicellular Systems) By Products (Vaccines, Enzymes, Others) Manufacturing Process (Single & Multi Use Systems) Application (Oncology, Cardiology, Others) End Users (Hospitals, Others) & Geography - Forecast(2018 - 2023)
Report Code : HCR 0054
Updated Date: 01 February, 2018  
5

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Global Biopharmaceutical Market Overview
2. Executive Summary
3. Global Biopharmaceutical Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. Patent Analysis
      3.2.3. End user profiling
      3.2.4. Top 5 Financials Analysis
4. Biopharmaceutical Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Biopharmaceutical Market Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunities Analysis
   5.3. Product lifecycle
   5.4. Pricing Analysis
6. Biopharmaceutical Market- By Source
   6.1. Unicellular System
      6.1.1. Bacteria
      6.1.2. Yeast
      6.1.3. Insect
   6.2. Multicellular System
      6.2.1. Transgenic Plant
      6.2.2. Transgenic Animal
7. Biopharmaceutical Market- By Products
   7.1. Vaccines
   7.2. Hormones
   7.3. Enzymes
   7.4. Blood
   7.5. Blood Components
   7.6. Monoclonal Antibodies
   7.7. Growth Factors
   7.8. Gene Therapies
   7.9. Thrombolytics and Anticoagulants
   7.10. Recombinant Therapeutic Protein
8. Biopharmaceutical Market- By Manufacturing Process
   8.1. Single-Use System
   8.2. Multi- Use System
9. Biopharmaceutical Market- By Application
   9.1. Rheumatology
   9.2. Oncology
   9.3. Cardiology
   9.4. Dermatology
   9.5. Gastroenterology
   9.6. Neurology
   9.7. Others
10. Biopharmaceutical Market- By End Users
   10.1. Biopharmaceutical Companies
   10.2. Hospitals
   10.3. Research Institutes
   10.4. CROs
   10.5. Diagnostic Labs
11. Biopharmaceutical Market -Geographic Analysis
   11.1. North America
      11.1.1. Canada
      11.1.2. Mexico
      11.1.3. USA
      11.1.4. Others
   11.2. Europe
      11.2.1. France
      11.2.2. Germany
      11.2.3. Italy
      11.2.4. Sweden
      11.2.5. U.K
      11.2.6. Others
   11.3. APAC
      11.3.1. China
      11.3.2. India
      11.3.3. Japan
      11.3.4. Australia
      11.3.5. Others
   11.4. ROW
      11.4.1. South Africa
      11.4.2. South America
      11.4.3. Russia
      11.4.4. Saudi Arabia
      11.4.5. Others
12.  Biopharmaceutical Market Entropy
   12.1. New Product Launches
   12.2. M&As, Collaborations, JVs and Partnerships
13.  Company profiles
   13.1. Johnson & Johnson Private Limited
   13.2. Roche Holding AG
   13.3. Abbott Laboratories
   13.4. Bristol-Myers Squibb
   13.5. Novartis International AG
   13.6. Genentech Inc.
   13.7. UCB
   13.8. Merck Serono
   13.9. Amgen
   13.10. Eli Lilly & Co.
   13.11. Biogen Idec
   13.12. Merck KGaA
   13.13. Élan Corporation
   13.14. BioMarin Pharmaceutical Inc.
   13.15. AbbVie Inc.
   13.16. Invion Limited
   13.17. AdAlta Pty Ltd.
   13.18. Admedus Ltd
   13.19. Biota Pharmaceuticals Inc.
   13.20. Novozymes
   13.21. Baxter International
   13.22. APEIRON Biologics AG
   13.23. Octapharma AG
   13.24. Valneva SE
   13.25. Genzyme
   13.26. Mallinckrodt Pharmaceuticals
   13.27. TM3 Therapeutics
*More than 30 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
14.  Appendix
   14.1. Abbreviations
   14.2. Sources
   14.3. Research Methodology
   14.4. Bibliography
   14.5. Compilation of Expert Insights
   14.6. Disclaimer
Biopharmaceuticals are large and complex products isolated from genetically modified living organisms. Recently, biologics or biopharmaceuticals is one of the fastest growing sectors of pharmaceutical industries, owing to its innovative nature, greater safety and efficacy compared to traditional drugs.

The market for Biopharmaceutical is classified into three categories based on source, type of products and application areas, each of these segments are further broken down into sub-segments to give a comprehensive analysis of global biopharmaceuticals market.

The overall Biopharmaceutical Market has also been presented from the perspective of different geographic locations and key economies in this market. Competitors are highlighted and market players are profiled with attributes covering company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of each of the prominent players for 2015 are detailed.

The market is largely dominated by North America which accounted for about half of the global share. APAC is a promising market and is opening gateways for new manufacturers.

The report also provides a detailed qualitative analysis of the factors responsible for driving and hindering the growth of the Biopharmaceuticals market and future opportunities that can propel the market.

The report contains the most detailed and in-depth segmentation and analysis of the Global Biopharmaceuticals Market during the forecast period 2015 - 2020.

Sample Companies Profiled in this Report are:
  • BioMarin Pharmaceutical Inc.
  • AbbVie Inc.
  • Invion Limited
  • AdAlta Pty Ltd.
  • Admedus Ltd
  • 30+.
List of Tables:

Table 1: Biopharmaceutical Market Overview 2017-2023
Table 2: Biopharmaceutical Market Leader Analysis 2017-2018 (US$)
Table 3: Biopharmaceutical Market Product Analysis 2017-2018 (US$)
Table 4: Biopharmaceutical Market End User Analysis 2017-2018 (US$)
Table 5: Biopharmaceutical Market Patent Analysis 2013-2018* (US$)
Table 6: Biopharmaceutical Market Financial Analysis 2017-2018 (US$)
Table 7: Biopharmaceutical Market Driver Analysis 2017-2018 (US$)
Table 8: Biopharmaceutical Market Challenges Analysis 2017-2018 (US$)
Table 9: Biopharmaceutical Market Constraint Analysis 2017-2018 (US$)
Table 10: Biopharmaceutical Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Biopharmaceutical Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Biopharmaceutical Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Biopharmaceutical Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Biopharmaceutical Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Biopharmaceutical Market Value Chain Analysis 2017-2018 (US$)
Table 16: Biopharmaceutical Market Pricing Analysis 2018-2023 (US$)
Table 17: Biopharmaceutical Market Opportunities Analysis 2018-2023 (US$)
Table 18: Biopharmaceutical Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Biopharmaceutical Market Supplier Analysis 2017-2018 (US$)
Table 20: Biopharmaceutical Market Distributor Analysis 2017-2018 (US$)
Table 21: Biopharmaceutical Market Trend Analysis 2017-2018 (US$)
Table 22: Biopharmaceutical Market Size 2017 (US$)
Table 23: Biopharmaceutical Market Forecast Analysis 2018-2023 (US$)
Table 24: Biopharmaceutical Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Biopharmaceutical Market, Revenue & Volume, By Source, 2018-2023 ($)
Table 26: Biopharmaceutical Market By Source, Revenue & Volume, By Unicellular System, 2018-2023 ($)
Table 27: Biopharmaceutical Market By Source, Revenue & Volume, By Bacteria, 2018-2023 ($)
Table 28: Biopharmaceutical Market By Source, Revenue & Volume, By Yeast, 2018-2023 ($)
Table 29: Biopharmaceutical Market By Source, Revenue & Volume, By Insect, 2018-2023 ($)
Table 30: Biopharmaceutical Market By Source, Revenue & Volume, By Multicellular System, 2018-2023 ($)
Table 31: Biopharmaceutical Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 32: Biopharmaceutical Market By Product, Revenue & Volume, By Vaccines, 2018-2023 ($)
Table 33: Biopharmaceutical Market By Product, Revenue & Volume, By Hormones, 2018-2023 ($)
Table 34: Biopharmaceutical Market By Product, Revenue & Volume, By Enzymes, 2018-2023 ($)
Table 35: Biopharmaceutical Market By Product, Revenue & Volume, By Blood, 2018-2023 ($)
Table 36: Biopharmaceutical Market By Product, Revenue & Volume, By Blood Components, 2018-2023 ($)
Table 37: Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2018-2023 ($)
Table 38: Biopharmaceutical Market By Manufacturing Process, Revenue & Volume, By Single-Use System, 2018-2023 ($)
Table 39: Biopharmaceutical Market By Manufacturing Process, Revenue & Volume, By Multi- Use System, 2018-2023 ($)
Table 40: Biopharmaceutical Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 41: Biopharmaceutical Market By Application, Revenue & Volume, By Rheumatology, 2018-2023 ($)
Table 42: Biopharmaceutical Market By Application, Revenue & Volume, By Oncology, 2018-2023 ($)
Table 43: Biopharmaceutical Market By Application, Revenue & Volume, By Cardiology, 2018-2023 ($)
Table 44: Biopharmaceutical Market By Application, Revenue & Volume, By Dermatology, 2018-2023 ($)
Table 45: Biopharmaceutical Market By Application, Revenue & Volume, By Gastroenterology, 2018-2023 ($)
Table 46: Biopharmaceutical Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 47: Biopharmaceutical Market By End Use, Revenue & Volume, By Biopharmaceutical Companies, 2018-2023 ($)
Table 48: Biopharmaceutical Market By End Use, Revenue & Volume, By Hospitals, 2018-2023 ($)
Table 49: Biopharmaceutical Market By End Use, Revenue & Volume, By Research Institutes, 2018-2023 ($)
Table 50: Biopharmaceutical Market By End Use, Revenue & Volume, By CROs, 2018-2023 ($)
Table 51: Biopharmaceutical Market By End Use, Revenue & Volume, By Diagnostic Labs, 2018-2023 ($)
Table 52: North America Biopharmaceutical Market, Revenue & Volume, By Source, 2018-2023 ($)
Table 53: North America Biopharmaceutical Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 54: North America Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2018-2023 ($)
Table 55: North America Biopharmaceutical Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 56: North America Biopharmaceutical Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 57: South america Biopharmaceutical Market, Revenue & Volume, By Source, 2018-2023 ($)
Table 58: South america Biopharmaceutical Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 59: South america Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2018-2023 ($)
Table 60: South america Biopharmaceutical Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 61: South america Biopharmaceutical Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 62: Europe Biopharmaceutical Market, Revenue & Volume, By Source, 2018-2023 ($)
Table 63: Europe Biopharmaceutical Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 64: Europe Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2018-2023 ($)
Table 65: Europe Biopharmaceutical Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 66: Europe Biopharmaceutical Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 67: APAC Biopharmaceutical Market, Revenue & Volume, By Source, 2018-2023 ($)
Table 68: APAC Biopharmaceutical Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 69: APAC Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2018-2023 ($)
Table 70: APAC Biopharmaceutical Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 71: APAC Biopharmaceutical Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 72: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Source, 2018-2023 ($)
Table 73: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 74: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2018-2023 ($)
Table 75: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 76: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 77: Russia Biopharmaceutical Market, Revenue & Volume, By Source, 2018-2023 ($)
Table 78: Russia Biopharmaceutical Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 79: Russia Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2018-2023 ($)
Table 80: Russia Biopharmaceutical Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 81: Russia Biopharmaceutical Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 82: Israel Biopharmaceutical Market, Revenue & Volume, By Source, 2018-2023 ($)
Table 83: Israel Biopharmaceutical Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 84: Israel Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2018-2023 ($)
Table 85: Israel Biopharmaceutical Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 86: Israel Biopharmaceutical Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 87: Top Companies 2017 (US$)Biopharmaceutical Market, Revenue & Volume
Table 88: Product Launch 2017-2018Biopharmaceutical Market, Revenue & Volume
Table 89: Mergers & Acquistions 2017-2018Biopharmaceutical Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Biopharmaceutical Market 2017-2023
Figure 2: Market Share Analysis for Biopharmaceutical Market 2017 (US$)
Figure 3: Product Comparison in Biopharmaceutical Market 2017-2018 (US$)
Figure 4: End User Profile for Biopharmaceutical Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Biopharmaceutical Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Biopharmaceutical Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Biopharmaceutical Market 2017-2018
Figure 8: Ecosystem Analysis in Biopharmaceutical Market 2017
Figure 9: Average Selling Price in Biopharmaceutical Market 2017-2023
Figure 10: Top Opportunites in Biopharmaceutical Market 2017-2018
Figure 11: Market Life Cycle Analysis in Biopharmaceutical Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy SourceBiopharmaceutical Market Revenue, 2018-2023 ($)
Figure 13: GlobalBy ProductBiopharmaceutical Market Revenue, 2018-2023 ($)
Figure 14: GlobalBy Manufacturing ProcessBiopharmaceutical Market Revenue, 2018-2023 ($)
Figure 15: GlobalBy ApplicationBiopharmaceutical Market Revenue, 2018-2023 ($)
Figure 16: GlobalBy End UseBiopharmaceutical Market Revenue, 2018-2023 ($)
Figure 17: Global Biopharmaceutical Market - By Geography
Figure 18: Global Biopharmaceutical Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 19: Global Biopharmaceutical Market CAGR, By Geography, 2018-2023 (%)
Figure 20: North America Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 21: US Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 22: US GDP and Population, 2017-2018 ($)
Figure 23: US GDP – Composition of 2017, By Sector of Origin
Figure 24: US Export and Import Value & Volume, 2017-2018 ($)
Figure 25: Canada Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 26: Canada GDP and Population, 2017-2018 ($)
Figure 27: Canada GDP – Composition of 2017, By Sector of Origin
Figure 28: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 29: Mexico Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 30: Mexico GDP and Population, 2017-2018 ($)
Figure 31: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 32: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 33: South America Biopharmaceutical Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 34: Brazil Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 35: Brazil GDP and Population, 2017-2018 ($)
Figure 36: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 37: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 38: Venezuela Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 39: Venezuela GDP and Population, 2017-2018 ($)
Figure 40: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 41: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 42: Argentina Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 43: Argentina GDP and Population, 2017-2018 ($)
Figure 44: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 45: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 46: Ecuador Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 47: Ecuador GDP and Population, 2017-2018 ($)
Figure 48: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 49: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 50: Peru Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 51: Peru GDP and Population, 2017-2018 ($)
Figure 52: Peru GDP – Composition of 2017, By Sector of Origin
Figure 53: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 54: Colombia Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 55: Colombia GDP and Population, 2017-2018 ($)
Figure 56: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 57: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 58: Costa Rica Biopharmaceutical Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 59: Costa Rica GDP and Population, 2017-2018 ($)
Figure 60: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 61: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 62: Europe Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 63: U.K Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 64: U.K GDP and Population, 2017-2018 ($)
Figure 65: U.K GDP – Composition of 2017, By Sector of Origin
Figure 66: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 67: Germany Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 68: Germany GDP and Population, 2017-2018 ($)
Figure 69: Germany GDP – Composition of 2017, By Sector of Origin
Figure 70: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 71: Italy Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 72: Italy GDP and Population, 2017-2018 ($)
Figure 73: Italy GDP – Composition of 2017, By Sector of Origin
Figure 74: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 75: France Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 76: France GDP and Population, 2017-2018 ($)
Figure 77: France GDP – Composition of 2017, By Sector of Origin
Figure 78: France Export and Import Value & Volume, 2017-2018 ($)
Figure 79: Netherlands Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 80: Netherlands GDP and Population, 2017-2018 ($)
Figure 81: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 82: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 83: Belgium Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 84: Belgium GDP and Population, 2017-2018 ($)
Figure 85: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 86: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 87: Spain Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 88: Spain GDP and Population, 2017-2018 ($)
Figure 89: Spain GDP – Composition of 2017, By Sector of Origin
Figure 90: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 91: Denmark Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 92: Denmark GDP and Population, 2017-2018 ($)
Figure 93: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 94: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 95: APAC Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 96: China Biopharmaceutical Market Value & Volume, 2018-2023
Figure 97: China GDP and Population, 2017-2018 ($)
Figure 98: China GDP – Composition of 2017, By Sector of Origin
Figure 99: China Export and Import Value & Volume, 2017-2018 ($)Biopharmaceutical Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 100: Australia Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 101: Australia GDP and Population, 2017-2018 ($)
Figure 102: Australia GDP – Composition of 2017, By Sector of Origin
Figure 103: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 104: South Korea Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 105: South Korea GDP and Population, 2017-2018 ($)
Figure 106: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 107: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 108: India Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 109: India GDP and Population, 2017-2018 ($)
Figure 110: India GDP – Composition of 2017, By Sector of Origin
Figure 111: India Export and Import Value & Volume, 2017-2018 ($)
Figure 112: Taiwan Biopharmaceutical Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 113: Taiwan GDP and Population, 2017-2018 ($)
Figure 114: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 115: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 116: Malaysia Biopharmaceutical Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 117: Malaysia GDP and Population, 2017-2018 ($)
Figure 118: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 119: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 120: Hong Kong Biopharmaceutical Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 121: Hong Kong GDP and Population, 2017-2018 ($)
Figure 122: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 123: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 124: Middle East & Africa Biopharmaceutical Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 125: Russia Biopharmaceutical Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 126: Russia GDP and Population, 2017-2018 ($)
Figure 127: Russia GDP – Composition of 2017, By Sector of Origin
Figure 128: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 129: Israel Biopharmaceutical Market Value & Volume, 2018-2023 ($)
Figure 130: Israel GDP and Population, 2017-2018 ($)
Figure 131: Israel GDP – Composition of 2017, By Sector of Origin
Figure 132: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 133: Entropy Share, By Strategies, 2017-2018* (%)Biopharmaceutical Market
Figure 134: Developments, 2017-2018*Biopharmaceutical Market
Figure 135: Company 1 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 136: Company 1 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 137: Company 1 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 138: Company 2 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 139: Company 2 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 140: Company 2 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 141: Company 3 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 142: Company 3 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 143: Company 3 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 144: Company 4 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 145: Company 4 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 146: Company 4 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 147: Company 5 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 148: Company 5 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 149: Company 5 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 150: Company 6 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 151: Company 6 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 152: Company 6 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 153: Company 7 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 154: Company 7 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 155: Company 7 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 156: Company 8 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 157: Company 8 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 158: Company 8 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 159: Company 9 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 160: Company 9 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 161: Company 9 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 162: Company 10 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 163: Company 10 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 164: Company 10 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 165: Company 11 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 166: Company 11 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 167: Company 11 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 168: Company 12 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 169: Company 12 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 170: Company 12 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 171: Company 13 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 172: Company 13 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 173: Company 13 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 174: Company 14 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 175: Company 14 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 176: Company 14 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Figure 177: Company 15 Biopharmaceutical Market Net Revenue, By Years, 2017-2018* ($)
Figure 178: Company 15 Biopharmaceutical Market Net Revenue Share, By Business segments, 2017 (%)
Figure 179: Company 15 Biopharmaceutical Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll